1. Volatile Oil of Acori Graminei Rhizoma-Induced Apoptosis and Autophagy are dependent on p53 Status in Human Glioma Cells
   Lu Chen et al, 2016, Sci Rep CrossRef
2. Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation
   Marie-Theres Zeuner et al, 2017, Mediators of Inflammation CrossRef
3. Effects of Some Growth Factors and Cytokines on the Expression of the Repair Enzyme MGMT and Protein MARP in Human Cells In Vitro
   Kateryna Kotsarenko et al, 2018, Biochem Genet CrossRef
4. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
   Zhiyun Yu et al, 2018, Cancer Lett CrossRef
5. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
   Meiling Yu et al, 2017, Biomed Pharmacother CrossRef
6. β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells
   Nanbu Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
7. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma
   Yanyu Zhang et al, 2018, Journal of Controlled Release CrossRef
8. Studies examining the synergy between Dihydrotanshinone and Temozolomide against MGMT+ glioblastoma cells in vitro: Predicting interactions with the blood-brain barrier
   Varun Kumar et al, 2019, Biomedicine & Pharmacotherapy CrossRef
9. Boswellic acid has anti‐inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells
   Manlio Barbarisi et al, 2019, Phytotherapy Research CrossRef
10. Antitumor activity of rhein lysinate against human glioma U87 cells in vitro and in vivo
    JIN LIU et al, 2016 CrossRef
11. Temozolomide resistance in glioblastoma multiforme.
    Sang Y Lee, 2016, Genes Dis CrossRef
12. The classical photoactivated drug 8-methoxypsoralen and related compounds are effective without UV light irradiation against glioma cells
    Diêgo Madureira de Oliveira et al, 2016, Neurochemistry International CrossRef
13. Antidepressant drugs can modify cytotoxic action of temozolomide
    A.M. Bielecka et al, 2017, Eur J Cancer Care CrossRef
14. β-Asarone promotes Temozolomide’s entry into glioma cells and decreases the expression of P-glycoprotein and MDR1
    Nanbu Wang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
15. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells
    Nanbu Wang et al, 2017, J Cell Physiol CrossRef
16. Distribution of positively charged amino acid residues in antimicrobial peptide epinecidin-1 is crucial for in vitro glioblastoma cytotoxicity and its underlying mechanisms
    Bor-Chyuan Su et al, 2019, Chemico-Biological Interactions CrossRef
17. NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature
    M. F. Candido et al, 2020, Childs Nerv Syst CrossRef
18. Comparative molecular characterization of typical and exceptional responders in glioblastoma
    Kristin Wipfler et al, 2018, Oncotarget CrossRef
19. NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
    Naze G. Avci et al, 2020, Sci Rep CrossRef
20. Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma
    Zili Zhai et al, 2020, Cancers CrossRef
21. Enhanced anti-inflammatory potential of degradation resistant curcumin/ferulic acid eutectics embedded in triglyceride-based microemulsions
    Farah Sanduk et al, 2020, Journal of Drug Delivery Science and Technology CrossRef
22. Astrocytes Decreased the Sensitivity of Glioblastoma Cells to Temozolomide and Bay 11-7082
    Sadaf E. Pustchi et al, 2020, IJMS CrossRef
23. Regulation of temozolomide resistance in glioma cells via the RIP2/NF‐κB/MGMT pathway
    Yu‐Hua Hu et al, 2021, CNS Neurosci Ther CrossRef
24. Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit.
    Michael Castro et al, 2021, J Neurooncol CrossRef
25. Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation
    Madineh Mazarei et al, 2021, Nanomaterials CrossRef
26. The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
    Mariana Medeiros et al, 2021, Cell. Mol. Life Sci. CrossRef
27. The Influence of Human Astrocyte-Conditioned Media on Glioblastoma Multiforme Response to Temozolomide and Bay 11-7082
    Sadaf E. Pustchi et al, 2022, IEEE Access CrossRef
28. Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma- an in vitro and in vivo perspective
    S. Daisy Precilla et al, 2022, Life Sciences CrossRef
29. Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma
    Muhammad Ismail et al, 2022, Biomaterials CrossRef
30. Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours-A Research Hypothesis.
    Wojciech Żwierełło et al, 2023, Int J Mol Sci CrossRef
31. Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP1
    FANBIAO KONG et al, 2022 CrossRef
32. Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling
    Martín Ledesma et al, 2023, Sci Rep CrossRef
33. A mini‐review on anticancer‐related properties of azithromycin and its potential activities in overcoming the challenges of glioblastoma
    Siti Nazihahasma Hassan et al, 2023, Fundamemntal Clinical Pharma CrossRef
34. 4-Methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells
    Matías A. Pibuel et al, 2023, Sci Rep CrossRef
35. Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase
    Vanishree Rao et al, 2023, CNSNDDT CrossRef
36. Modulating MGMT expression through interfering with cell signaling pathways
    Peiying Bai et al, 2023, Biochemical Pharmacology CrossRef
37. Combination Drug Therapy of Glioblastoma: Lessons from 3D In Vitro Models and the Roadmap for Future Research
    Mahsa Vaezzadeh et al, 2023, Advanced Therapeutics CrossRef
38. Unlocking Glioblastoma Secrets: Natural Killer Cell Therapy against Cancer Stem Cells
    Yuanning Du et al, 2023, Cancers CrossRef
39. Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma
    Zongze He et al, 2024, Genes & Diseases CrossRef
40. RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway
    Qian Sun et al, 2024, Cancer Biology & Therapy CrossRef